Abstract:Background: Metastasis-associated protein 2 (MTA2) is a member of the metastasis-associated transcriptional regulator family and is a core component of the nucleosome remodeling and histone deacetylation complex. Despite growing evidence that MTA2 plays a crucial role in the tumorigenesis of certain cancers, no systematic pan-cancer analysis of MTA2 is available to date. Therefore, the aim of our study is to explore the prognostic value of MTA2 in 33 cancer types and to investigate its potential immune function. Methods: by comprehensive use of databases from TCGA, GTEx, GEO, UCSC xena, cBioPortal, comPPI, GeneMANIA, TCIA, MSigDB, and PDB, we applied various bioinformatics approaches to investigate the potential role of MTA2, including analyzing the association of MTA2 with MSI, prognosis, gene mutation, and immune cell infiltration in different tumors. We constructed a nomogram in TCGA-LIHC, performed single-cell sequencing (scRNA-seq) analysis of MTA2 in hepatocellular carcinoma (HCC), and screened drugs for the treatment of HCC. Finally, immunohistochemical experiments were performed to verify the expression and prognostic value of MTA2 in HCC. In vitro experiments were employed to observe the growth inhibition effects of MK-886 on the HCC cell line HepG2. Results: The results suggested that MTA2 was highly expressed in most cancers, and MTA2 expression was associated with the prognosis of different cancers. In addition, MTA2 expression was associated with Tumor Mutation Burden (TMB) in 12 cancer types and MSI in 8 cancer types. Immunoassays indicated that MTA2 positively correlated with activated memory CD4 T cells and M0 macrophage infiltration levels in HCC. ScRNA-seq analysis based on the GEO dataset discovered that MTA2 was significantly expressed in T cells in HCC. Finally, the eXtreme Sum (Xsum) algorithm was used to screen the antitumor drug MK-886, and the molecular docking technique was utilized to reveal the binding capacity between MK-886 and the MTA2 protein. The results demonstrated excellent binding sites between them, which bind to each other through Π-alkyl and alkyl interaction forces. An immunohistochemistry experiment showed that MTA2 protein was highly expressed in HCC, and high MTA2 expression was associated with poor survival in HCC patients. MK-886 significantly inhibited the proliferation and induced cell death of HepG2 cells in a dose-dependent manner. Conclusions: Our study demonstrated that MTA2 plays crucial roles in tumor progression and tumor immunity, and it could be used as a prognostic marker for various malignancies. MK-886 might be a powerful drug for HCC.

Bioinformatic Exploration of Mta1-Regulated Gene Networks in Colon Cancer

Delineating the Underlying Molecular Mechanisms and Key Genes Involved in Metastasis of Colorectal Cancer Via Bioinformatics Analysis

Unravelling The Complexity And Functions Of Mta Coregulators In Human Cancer

MTA1 is Up-regulated in Colorectal Cancer and is Inversely Correlated with Lymphatic Metastasis.

Clinical Significance of Overexpression of Metastasis-Associated Gene MTA1 in Cervical Cancer and Bioinformatic Analysis of Genes Coordinately Expressed with MTA1

Upregulation of MTA1 in Colon Cancer Drives A CD8+ T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment

MTA 1 , an independent prognostic factor , promotes melanoma cell invasion by induction of EMT

Gene Profiling of MTA1 Identifies Novel Gene Targets and Functions.

Role of MTA1 in Cancer Progression and Metastasis

Molecular Functions and Significance of the Mta Family in Hormone-Independent Cancer

Explore Key Genes and Mechanisms Involved in Colon Cancer Progression Based on Bioinformatics Analysis

Integrated bioinformatics analysis of key genes involved in progress of colon cancer.

MTA1-TJP1 Interaction and Its Involvement in Non-Small Cell Lung Cancer Metastasis

Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma

Role of Metastasis-Associated Protein 1 in Prognosis of Patients with Digestive Tract Cancers: A Meta-Analysis

Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer

Mining and Analysis of Prognosis-Related Mutant Gene Groups in Colon Cancer Based on the Cancer Genome Atlas

Expression of MTA1 Protein in Non-Small Cell Lung Cancer and Its Association with the Prognosis of the Disease

Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis

SNP Mutation‐related Genes in Colon Cancer for Monitoring and Prognosis of Patients: A Study Based on the TCGA Database

Metastasis-Associated Protein 1/nucleosome Remodeling and Histone Deacetylase Complex in Cancer